Related Experiment Videos
[Gastric leiomyosarcomas and leiomyoblastomas]
S R Sobrino Cossio1, V A García Guerrero, E Pérez Torres
1Hospital General de México, SS., Servicio de Gastroenterología.
Revista De Gastroenterologia De Mexico
|January 1, 1995
Summary
This study analyzed stomach smooth muscle tumors (SMTS), excluding leiomyomas, finding leiomyosarcomas and leiomyoblastomas. Surgical mortality was high at 27.2%, highlighting the aggressive nature of these gastric neoplasms.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Pathology
Context:
- Smooth muscle tumors of the stomach (SMTS) are rare neoplasms.
- Accurate diagnosis and appropriate management are crucial for patient outcomes.
- This study focuses on non-leiomyomatous SMTS, differentiating between leiomyosarcomas and leiomyoblastomas.
Purpose:
- To review cases of non-leiomyomatous smooth muscle tumors of the stomach (SMTS) diagnosed at a major hospital over five years.
- To analyze the clinical presentation, diagnostic methods, tumor characteristics, and treatment outcomes.
- To identify histological criteria for differentiating leiomyosarcomas (LMS) from leiomyoblastomas (LMB).
Summary:
- Eleven cases of non-leiomyomatous SMTS were identified (8 LMS, 3 LMB) in patients with an average age of 51.3 years.
- Common symptoms included anemia, digestive bleeding, and abdominal pain, with diagnosis aided by barium radiology and endoscopy.
- Tumor sizes ranged from 1.5-28 cm, predominantly located in the gastric fundus. Histological differentiation relied on mitotic count, size, and hypercellularity.
- Surgical mortality was 27.2%, with poorer outcomes in emergency surgery cases.
Impact:
- Provides insights into the clinical behavior and pathological features of rare gastric smooth muscle tumors.
- Highlights diagnostic challenges and the importance of histological differentiation for treatment planning.
- Underscores the significant surgical morbidity and mortality associated with these tumors, informing prognosis and management strategies.